HbA1c Control Material
- UID
- IMP/IVD/2020/000617_180e1d334d491fbf24977bb149527ff1_03b8e815d4d9d96c54feed36b4cb71c2
- Device class
- Class B
- Brand name
- Lifotronic
- License holder
- Matrix Labs
- Approving authority
- CDSCO
- Product information
- HbA1c Control Material is intended for the system quality control for accuracy and repeatability.,ß-THALASSAEMIA & HbA1c Reagent Kit (Lifotronic)(Lifotronic)-Beta-thalassemia Analysis Mode is intended for IN VITRO DIAGNOSTIC USE ONLY for the separation and area percent determinations of Hemoglobin HbA2HbF and HbA1c and as an aid in the presumptive identification of abnormal human hemoglobins in whole blood using ion-exchange high performance liquid chromatography (Lifotronic). This result can be used for reference of clinical β-thalassaemia diagnose
HbA1c Control Material is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000617_180e1d334d491fbf24977bb149527ff1_03b8e815d4d9d96c54feed36b4cb71c2. This device is marketed under the brand name Lifotronic. The license holder is Matrix Labs, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.